Substituted quinazoline and pyridopyrimidine derivatives useful as anticancer agents
申请人:PFIZER INC.
公开号:US10662204B2
公开(公告)日:2020-05-26
Compounds of the general formula:
processes for the preparation of these compounds, compositions containing these compounds, and administration of these compounds to patients to treat pancreatic, lung, colon and other cancers.
SUBSTITUTED QUINAZOLINE AND PYRIDOPYRIMIDINE DERIVATIVES USEFUL AS ANTICANCER AGENTS
申请人:Pfizer Inc.
公开号:EP3746435A1
公开(公告)日:2020-12-09
US4853414A
申请人:——
公开号:US4853414A
公开(公告)日:1989-08-01
[EN] SUBSTITUTED QUINAZOLINE AND PYRIDOPYRIMIDINE DERIVATIVES USEFUL AS ANTICANCER AGENTS<br/>[FR] DÉRIVÉS DE QUINAZOLINE ET DE PYRIDOPYRIMIDINE SUBSTITUÉS UTILES EN TANT QU'AGENTS ANTICANCÉREUX
申请人:PFIZER
公开号:WO2019150305A1
公开(公告)日:2019-08-08
Compounds of the general formula (I): processes for the preparation of these compounds, compositions containing these compounds, and compounds (I) for use as inhibitors of the KRAS protein for the tretament of cancer.